Global Neurovascular Intervention Market - (By Type-Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System; By Region- North America, Europe & Asia Pacific) Market Outlook 2024
November 30, 2018
Rockville Research
82
PDF
Global Neurovascular Intervention Market - (By Type-Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System; By Region- North America, Europe & Asia Pacific) Market Outlook 2024
Abstract Neurovascular intervention encompasses diagnosis, treatment and prevention of vascular disorders affecting central nervous system (brain and spine). Neurovascular disorders or diseases refers to abnormality associated within blood vessels supplying blood to the brain and spine. It leads to reduction of blood flow to the brain and increases the risk of stroke (particularly “ischemic” stroke), and weakens the arteries, which might lead to brain aneurysms while increasing the risk of intracranial bleeding (or “hemorrhagic” stroke).
Neurovascular disorders often lead to considerable morbidity in patients, which requires special attention to be paid to this disability and its rehabilitation. Growth of global neurovascular intervention market is propelled by rising prevalence of cerebrovascular diseases, higher incidences of neurological disorders, favorable reimbursement policies and expanding healthcare infrastructure. However, the market faces several challenges such as high treatment cost, multiple product recalls, dearth of skilled neurosurgeons and social stigma.
The report “Global Neurovascular Intervention Market – (By Type-Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System; By Region- North America, Europe & Asia Pacific) Market Outlook 2024” provides in-depth analysis of the current scenario, detailed market outlook of the global neurovascular intervention market with coverage on major market segments such as Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System. Future forecasts of neurovascular intervention overall and across various sub-segments till 2024 is provided in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global neurovascular intervention market include Johnson & Johnson DePuy Synthes, Stryker Corporation, Medtronic Plc., Penumbra Inc., Terumo Corporation, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global neurovascular intervention market.
Content 1. Executive Summary 2. Research Methodology 3. Neurovascular Market 3.1 Introduction 3.1.1 Background 3.1.2 Neurovascular Devices 3.2 Market Analysis 3.2.1 Market Sizing (Actual & Forecasted) 3.2.2 Market Share by Region 3.2.3 Market Share by Therapeutic Application 3.2.4 Market Share by Technique 4. Global Neurovascular Market Segmentation 4.1 Cerebral Thrombectomy Devices 4.1.1 Overview 4.1.2 Market Sizing (Actual & Forecasted) 4.1.3 Market Share by Region 4.2 Flow Diverter for Aneurysm 4.2.1 Overview 4.2.2 Market Sizing (Actual & Forecasted) 4.2.3 Market Share by Region 4.3 Carotid Artery Stenting (CAS) System 4.3.1 Overview 4.3.2 Market Sizing (Actual & Forecasted) 4.3.3 Market Share by Region 4.4 Stent Retriever Market 4.4.1 Overview 4.4.2 Market Sizing (Actual & Forecasted) 5. Regional Analysis 5.1 North America (The US) 5.1.1 Market Sizing (Actual & Forecasted) 5.1.2 Market Share by Segment 5.1.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted) 5.1.4 Flow Diverter Devices Market Sizing (Actual & Forecasted) 5.1.5 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted) 5.2 Europe 5.2.1 Market Sizing (Actual & Forecasted) 5.2.2 Market Share by Segment 5.2.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted) 5.2.4 Flow Diverter Devices Market Sizing (Actual & Forecasted) 5.3 Asia Pacific 5.3.1 Market Sizing (Actual & Forecasted) 5.3.2 Market Share by Segment 5.3.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted) 6. Global Neurovascular Market Dynamics 6.1 Industry Trends & Developments 6.1.1 Mergers & Acquisitions 6.1.2 Technological Advancement 6.1.3 Advent of ARTS (Aspiration-Retriever Technique for Stroke) 6.2 Growth Drivers 6.2.1 Rising Prevalence of Cerebrovascular disease 6.2.2 Higher Incidences of Neurological Disorders 6.2.3 Favorable Reimbursement Policies 6.2.4 Expanding Healthcare Infrastructure 6.3 Challenges 6.3.1 High Cost of Treatment 6.3.2 Multiple Product Recalls 6.3.3 Dearth of Skilled Neurosurgeons 6.3.4 Social Stigma 7. Competitive Landscape 7.1 Global 7.2 Regional 8. Company Profiles 8.1 Johnson & Johnson DePuy Synthes 8.2 Stryker Corporation 8.3 Medtronic Plc. 8.4 Penumbra Inc. 8.5 Terumo Corporation
Neurovascular intervention encompasses diagnosis, treatment and prevention of vascular disorders affecting central nervous system (brain and spine). Neurovascular disorders or diseases refers to abnormality associated within blood vessels supplying blood to the brain and spine. It leads to reduction of blood flow to the brain and increases the risk of stroke (particularly “ischemic” stroke), and weakens the arteries, which might lead to brain aneurysms while increasing the risk of intracranial bleeding (or “hemorrhagic” stroke).
Neurovascular disorders often lead to considerable morbidity in patients, which requires special attention to be paid to this disability and its rehabilitation. Growth of global neurovascular intervention market is propelled by rising prevalence of cerebrovascular diseases, higher incidences of neurological disorders, favorable reimbursement policies and expanding healthcare infrastructure. However, the market faces several challenges such as high treatment cost, multiple product recalls, dearth of skilled neurosurgeons and social stigma.
The report “Global Neurovascular Intervention Market – (By Type-Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System; By Region- North America, Europe & Asia Pacific) Market Outlook 2024” provides in-depth analysis of the current scenario, detailed market outlook of the global neurovascular intervention market with coverage on major market segments such as Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System. Future forecasts of neurovascular intervention overall and across various sub-segments till 2024 is provided in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global neurovascular intervention market include Johnson & Johnson DePuy Synthes, Stryker Corporation, Medtronic Plc., Penumbra Inc., Terumo Corporation, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global neurovascular intervention market.
1. Executive Summary 2. Research Methodology 3. Neurovascular Market 3.1 Introduction 3.1.1 Background 3.1.2 Neurovascular Devices 3.2 Market Analysis 3.2.1 Market Sizing (Actual & Forecasted) 3.2.2 Market Share by Region 3.2.3 Market Share by Therapeutic Application 3.2.4 Market Share by Technique 4. Global Neurovascular Market Segmentation 4.1 Cerebral Thrombectomy Devices 4.1.1 Overview 4.1.2 Market Sizing (Actual & Forecasted) 4.1.3 Market Share by Region 4.2 Flow Diverter for Aneurysm 4.2.1 Overview 4.2.2 Market Sizing (Actual & Forecasted) 4.2.3 Market Share by Region 4.3 Carotid Artery Stenting (CAS) System 4.3.1 Overview 4.3.2 Market Sizing (Actual & Forecasted) 4.3.3 Market Share by Region 4.4 Stent Retriever Market 4.4.1 Overview 4.4.2 Market Sizing (Actual & Forecasted) 5. Regional Analysis 5.1 North America (The US) 5.1.1 Market Sizing (Actual & Forecasted) 5.1.2 Market Share by Segment 5.1.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted) 5.1.4 Flow Diverter Devices Market Sizing (Actual & Forecasted) 5.1.5 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted) 5.2 Europe 5.2.1 Market Sizing (Actual & Forecasted) 5.2.2 Market Share by Segment 5.2.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted) 5.2.4 Flow Diverter Devices Market Sizing (Actual & Forecasted) 5.3 Asia Pacific 5.3.1 Market Sizing (Actual & Forecasted) 5.3.2 Market Share by Segment 5.3.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted) 6. Global Neurovascular Market Dynamics 6.1 Industry Trends & Developments 6.1.1 Mergers & Acquisitions 6.1.2 Technological Advancement 6.1.3 Advent of ARTS (Aspiration-Retriever Technique for Stroke) 6.2 Growth Drivers 6.2.1 Rising Prevalence of Cerebrovascular disease 6.2.2 Higher Incidences of Neurological Disorders 6.2.3 Favorable Reimbursement Policies 6.2.4 Expanding Healthcare Infrastructure 6.3 Challenges 6.3.1 High Cost of Treatment 6.3.2 Multiple Product Recalls 6.3.3 Dearth of Skilled Neurosurgeons 6.3.4 Social Stigma 7. Competitive Landscape 7.1 Global 7.2 Regional 8. Company Profiles 8.1 Johnson & Johnson DePuy Synthes 8.2 Stryker Corporation 8.3 Medtronic Plc. 8.4 Penumbra Inc. 8.5 Terumo Corporation